MEDICAL RESEARCH, CONNECTED
A new foundation for researchers, clinicians, and life sciences organizations to work together. Built around a vision of controlled data access, accountable AI, and patient privacy.
Platform concept / All four divisions are planned
Research institutions Clinical collaborators Life sciences Research participants
01 / THE PLATFORM
Bring knowledge together while respecting the boundaries around it. Explore the proposed capabilities of each Hybrid Discovery division.
Keep valuable research data under deliberate control.
A proposed home for medical and pharmaceutical datasets, with institution-defined custody, permissions, and permitted uses.
Give complex cases a wider circle of expertise.
A proposed workspace for physicians and specialists to exchange case insights with appropriate permissions and professional accountability.
Make research participation more understandable.
A proposed connection between study teams and participants, with clear research purposes, controlled disclosure, and study-specific permissions.
Explore medical intelligence with accountability.
A proposed environment for AI-assisted research across institutions, combining federated approaches with purpose limits and privacy evaluation.
A vision, with clear boundaries. All four divisions and their workflows are planned. This preview introduces the platform; it does not collect medical data, enroll participants, or provide clinical services.
02 / THE PRIVACY APPROACH
The goal is useful collaboration with explicit boundaries: who can participate, what they can access, and how the results may be used.
Why patient-level privacy mattersPlanned access would distinguish a signed-in person, a verified professional role, and permission for a specific study or dataset.
The intended architecture favors institution-controlled data and approved computation. Sensitive medical records would stay off the public blockchain.
Federated learning alone is insufficient. The roadmap calls for patient-level privacy testing, appropriate protections, and review of outputs.
Research purposes, access periods, and withdrawal limits should be explained before participation. Shared sign-in would not automatically share medical data.
03 / THE HYBRID ECOSYSTEM
Hybrid Discovery is envisioned as the medical research vertical of the wider Hybrid ecosystem. These are proposed integration roles, not live Discovery connections.
Medical research
with purpose and permission.
Authentication, accountable identities, and separately authorized access.
Selected provenance and settlement workflows, where appropriate.
AI orchestration within approved research purposes and task boundaries.
Coordination and computation across participating institutional environments.
Connecting an identity or an AI agent would not itself grant access to patient data, permission to act clinically, or authority to spend.
A SHARED RESEARCH JOURNEY
Follow a fictional recovery study across the four planned divisions. Each stage has its own purpose, responsible people, and access decision.
Find appropriate resources and review a specific use.
Explain the study and record specific choices.
Bring in authorized professional expertise.
Run an approved analysis and review outputs.
04 / THE PATH FORWARD
A proposed sequence, with progress tied to working evidence. No launch dates or service availability are committed.
Review the four-division vision, institutional needs, data boundaries, and the first research collaboration use case.
This website is the review starting point.Propose Vault and one collaboration workflow. Test identity, permissions, data custody, and privacy before broader use.
Requires implementation and partner validation.Develop Clinical, Trials, and AI workflows as their professional, participant, and operational requirements are met.
Each capability needs its own readiness review.A FEW IMPORTANT DETAILS
This website is a presentation of the Hybrid Discovery concept. You can explore the four divisions, their planned scope, and the proposed architecture. Research tools, data uploads, clinical collaboration, trial enrollment, and AI services are not available here.
The proposed product is infrastructure for medical research and professional collaboration. This website offers no patient care or diagnosis service. The Clinical vision keeps care decisions with qualified treating professionals.
Direct patient participation is part of the longer-term Trials vision. Proposed workflows include study information, specific permissions, and participation records. No patient data contribution or compensation program is currently offered.
No. Keeping data distributed does not eliminate the possibility that a model reveals information about its training data. The proposed AI approach therefore includes patient-level risk evaluation, appropriate privacy protections, and controlled output access. These protections still need to be implemented and validated.
No. A proposed Hybrid-ID integration would establish who is signing in. Dataset access, professional permissions, study participation, and optional disclosures would require separate authorization. Discovery sign-in is not connected in this preview.
THE NEXT CHAPTER OF DISCOVERY
Explore the vision. Help shape what comes next.